Molly Aggas | Account Supervisor, Dalton Agency |
A.J. Kazimi | CEO |
Todd Anthony | VP, Organizational Development |
John Hamm | CFO |
Good afternoon, and welcome to Cumberland Pharmaceuticals' 2022 Financial Report and Company Update. This call is being recorded at Cumberland's request and will be archived on the company's website for one year from today's date.
I would now like to turn it over to Molly Aggas, Account Supervisor at the Dalton Agency, who handles Cumberland's Communications. Molly, please go ahead.
Hello, everyone, and good afternoon.